Steven Mennen – Biography

Last update: February 1, 2026

Executive profile

Steven was Executive Director and Head of Chemistry, Manufacturing and Controls at Fulcrum Therapeutics, and Principal Scientist at Amgen. Steven Mennen joined Accent Therapeutics in 2023.

Steven Mennen is currently

Vice President of Pre-Clinical Development at Accent Therapeutics - View - Accent Therapeutics org chart



Create your alert
to follow the career of Steven Mennen.

Education

Steven Mennen has a PhD in Organic Chemistry from Yale University.

They have also studied at Yale University :

Find more alumni from Yale University

The colleagues of Steven Mennen

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Steven Mennen has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Steven Mennen.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Accent Therapeutics at +1 339... and ask for Steven Mennen.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.